Astrocytoma - Pipeline Review, H2 2013

Global Markets Direct
July 31, 2013
61 Pages - SKU: GMD5092021
Anxiety Disorders-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Anxiety Disorders-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Anxiety Disorders-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Tension -Type Headache-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Tension -Type Headache-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Tension -Type Headache-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed  |  read more...
USD 2,000
Autism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Autism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Autism-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Autism.  |  read more...
USD 2,000
Brain Hemorrhage-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Brain Hemorrhage-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Brain Hemorrhage-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Depression-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Depression-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Depression-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Depression.  |  read more...
USD 2,000
Malignant Glioma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Malignant Glioma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Malignant Glioma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Restless Legs Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Restless Legs Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Restless Legs Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed  |  read more...
USD 2,000
Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs  |  read more...
USD 2,000
Obsessive-Compulsive Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Obsessive-Compulsive Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Obsessive-Compulsive Disorder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 2,000  
    Site License  USD 4,000  
    Global Site License  USD 6,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!